Abstract
Influence of Medical Insurance Reimbursement on Medical Costs for Patients With Psoriasis Since Coverage of Adalimumab by National Reimbursement Drug List: A 4-Year Single-Center Retrospective Study in China
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Dermatology and Venereology
Paper Title
Journal
Date
